Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines

被引:19
|
作者
Binder, Zev A. [1 ,2 ,3 ,7 ]
Wilson, Kelli M. [1 ,8 ]
Salmasi, Vafi [1 ,9 ]
Orr, Brent A. [4 ,10 ]
Eberhart, Charles G. [4 ]
Siu, I-Mei [1 ]
Lim, Michael [1 ,5 ]
Weingart, Jon D. [1 ,5 ]
Quinones-Hinojosa, Alfredo [1 ,5 ]
Bettegowda, Chetan [1 ,5 ]
Kassam, Amin B. [6 ]
Olivi, Alessandro [1 ,5 ]
Brem, Henry [1 ,5 ]
Riggins, Gregory J. [1 ,5 ]
Gallia, Gary L. [1 ,5 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA
[3] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[6] Aurora Neurosci Innovat Inst, Dept Neurosurg, Milwaukee, WI USA
[7] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA
[8] NIH, Div Preclin Innovat, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA
[9] Cleveland Clin, Inst Anesthesiol, Cleveland, OH 44106 USA
[10] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
来源
PLOS ONE | 2016年 / 11卷 / 03期
基金
美国国家卫生研究院;
关键词
STEM-CELLS; CROSS-CONTAMINATION; TUMOR; RESISTANCE; PHENOTYPE; GENOTYPE; CULTURE; GROWTH;
D O I
10.1371/journal.pone.0150271
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective Human tumor cell lines form the basis of the majority of present day laboratory cancer research. These models are vital to studying the molecular biology of tumors and preclinical testing of new therapies. When compared to traditional adherent cell lines, suspension cell lines recapitulate the genetic profiles and histologic features of glioblastoma multiforme (GBM) with higher fidelity. Using a modified neural stem cell culture technique, here we report the characterization of GBM cell lines including GBM variants. Methods Tumor tissue samples were obtained intra-operatively and cultured in neural stem cell conditions containing growth factors. Tumor lines were characterized in vitro using differentiation assays followed by immunostaining for lineage-specific markers. In vivo tumor formation was assayed by orthotopic injection in nude mice. Genetic uniqueness was confirmed via short tandem repeat (STR) DNA profiling. Results Thirteen oncosphere lines derived from GBM and GBM variants, including a GBM with PNET features and a GBM with oligodendroglioma component, were established. All unique lines showed distinct genetic profiles by STR profiling. The lines assayed demonstrated a range of in vitro growth rates. Multipotency was confirmed using in vitro differentiation. Tumor formation demonstrated histologic features consistent with high grade gliomas, including invasion, necrosis, abnormal vascularization, and high mitotic rate. Xenografts derived from the GBM variants maintained histopathological features of the primary tumors. Conclusions We have generated and characterized GBM suspension lines derived from patients with GBMs and GBM variants. These oncosphere cell lines will expand the resources available for preclinical study.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] The prognostic significance of volumetry in patients with glioblastoma multiforme (GBM)
    Iliadis, G.
    Selviaridis, P.
    Kalogera-Fountzila, A.
    Fragkoulidi, A.
    Baltas, D.
    Misailidou, D.
    Zamboglou, N.
    Fountzilas, G.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 498 - 498
  • [22] Defining subclonal signaling heterogeneity in glioblastoma multiforme (GBM)
    Lan, Xiaoyang
    Meyer, Mona
    Reimand, Jueri
    Zhu, Xueming
    Kushida, Michelle
    Head, Renee
    Clarke, Ian
    Bader, Gary
    Dirks, Peter
    [J]. CANCER RESEARCH, 2013, 73
  • [23] The effect of triptolide on apoptosis of glioblastoma multiforme (GBM) cells
    Lin, J.
    Chen, L-Y
    Lin, Z-X
    Zhao, M-L
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2007, 35 (05) : 637 - 643
  • [24] PERSONALIZING DRUG SCREENING FOR GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
    Jiang, Pengfei
    Chao, Ying
    Gallagher, Matthew
    Kim, Ryan
    Pastorino, Sandra
    Fogal, Valentina
    Kesari, Santosh
    [J]. NEURO-ONCOLOGY, 2011, 13 : 58 - 58
  • [25] Bevacizumab and irinotecan in patients with recurrent glioblastoma multiforme (GBM)
    Raval, Sumul N.
    Rule, Amy
    Hwang, Shirley S.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [26] Overexpression of FAT1 in human GBM (glioblastoma multiforme) and high-grade glioma cell lines
    Dikshit, Bhawana
    Chosdol, Kunzang
    Sinha, Subrata
    [J]. CANCER RESEARCH, 2011, 71
  • [27] Design and synthesis of novel caffeic acid phenethyl ester (CAPE) derivatives and their biological activity studies in glioblastoma multiforme (GBM) cancer cell lines
    Sucu, Bilgesu Onur
    Koc, Elif Beyza
    Ipek, Ozgecan Savlug
    Mirat, Afranur
    Almas, Furkan
    Guzel, Melike Aybala
    Dogan, Berna
    Uludag, Damla
    Karakas, Nihal
    Durdagi, Serdar
    Guzel, Mustafa
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 113
  • [28] Cell cycle pathway gene regulation in glioblastoma multiforme (GBM) and GBM derived stem cells: Implicating Pentraxin 3 upregulation
    Wesley, Umadevi V.
    Clark, Paul
    Jaeger, Jacob
    Kuo, John
    Dempsey, Robert
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [29] Ultrastructural characterization of primary cilia in pathologically characterized human glioblastoma multiforme (GBM) tumors
    Moser, Joanna J.
    Fritzler, Marvin J.
    Rattner, Jerome B.
    [J]. BMC CLINICAL PATHOLOGY, 2014, 14
  • [30] LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis
    Li, Qi
    Jia, Hongmei
    Li, Haowen
    Dong, Chengya
    Wang, Yajie
    Zou, Zhongmei
    [J]. TUMOR BIOLOGY, 2016, 37 (11) : 14537 - 14552